A Study of Intermittent Oral Dosing of ASP1517 in Erythropoieses Stimulating Agent (ESA)-Naive Hemodialysis Chronic Kidney Disease Patients With Anemia

NCT02780141 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

ESA-naive Hemodialysis Chronic Kidney Disease Patients With Anemia

Interventions

DRUG: roxadustat

Sponsor

Astellas Pharma Inc

Collaborators

[object Object]